BioStem Technologies Inc. Company Profile
NASDAQ: BSEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioStem Technologies at a glance
BioStem Technologies Inc. (NASDAQ: BSEM) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Fort Lauderdale, FL. BioStem Technologies employs about 73 people. At a market capitalization of $12.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001658678, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does BioStem Technologies do?
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- BioStem Technologies Inc.
- Ticker
- NASDAQ: BSEM
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 73
- Headquarters
- 4901 Northwest 17th Way, Fort Lauderdale, FL, United States
- Phone
- 954 380 8342
- Website
- biostemtechnologies.com
- Market cap
- $12.18M
- SEC CIK
- 0001658678
Companies similar to BioStem Technologies
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BCDABioCardia Inc. | 0.785 | +1.60% | $11.88M | vs BSEM |
| PASGPassage Bio Inc. | 3.92 | +11.68% | $12.61M | vs BSEM |
| DYAIDyadic International Inc. | 0.287 | -7.66% | $11.51M | vs BSEM |
| ABOSAcumen Pharmaceuticals Inc. | 0.1865 | -3.52% | $13.49M | vs BSEM |
| PLURPluri Inc. | 0.94 | -3.07% | $13.51M | vs BSEM |
| ESLAEstrella Immunopharma Inc. | 0.321 | -5.70% | $14.11M | vs BSEM |
| TCRXTScan Therapeutics Inc. | 0.1459 | +2.24% | $9.89M | vs BSEM |
| ATYRaTyr Pharma Inc. | 3.82 | +3.52% | $9.74M | vs BSEM |